A phase I study of GT-103 in patients with advanced-stage solid tumors

Next Previous
Trial Profile

A phase I study of GT-103 in patients with advanced-stage solid tumors

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs GT-103 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man

    • Most Recent Events

    • 30 Aug 2017 New trial record
    • 22 Aug 2017 According to a Grid Therapeutics media release, the company plans to begin the trial in early 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top